Provided By PR Newswire
Last update: May 20, 2025
NEW YORK, May 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. ("ICU" or the "Company") (NASDAQ: ICUI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:ICUI (8/12/2025, 2:55:08 PM)
111.243
+3.14 (+2.91%)
Find more stocks in the Stock Screener